Pharmigene, Inc. (TPEX:7595)
Taiwan · Delayed Price · Currency is TWD 7.42
+0.07 (0.95%)
Aug 19, 2026, 11:57 AM CST
Pharmigene Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 87.58 | 56.49 | 92.34 | 68.53 | 76.86 | 104.29 |
Short-Term Investments | 5 | 28.97 | 31.96 | 38.81 | 118.73 | 134.8 |
Trading Asset Securities | - | - | 34.34 | 53.43 | - | - |
Cash & Short-Term Investments | 92.58 | 85.46 | 158.64 | 160.78 | 195.59 | 239.09 |
Cash Growth | 23.11% | -46.13% | -1.33% | -17.80% | -18.19% | -19.63% |
Accounts Receivable | 17.28 | 53.16 | 12.87 | 25.66 | 27.43 | 17.31 |
Other Receivables | 0.36 | 0.47 | 0.68 | 0.49 | 1.15 | 0.03 |
Receivables | 17.65 | 53.63 | 13.55 | 26.15 | 28.58 | 17.34 |
Inventory | 34.06 | 44.23 | 53.68 | 27.44 | 28.57 | 18.71 |
Prepaid Expenses | 3.38 | 33.68 | 21.3 | 17.92 | 5.39 | 10.65 |
Other Current Assets | 2.25 | 2.02 | 3.07 | 21.7 | 0.4 | 0.3 |
Total Current Assets | 149.91 | 219 | 250.25 | 253.99 | 258.54 | 286.09 |
Property, Plant & Equipment | 536.83 | 539.99 | 593.89 | 559.95 | 28.35 | 36.73 |
Long-Term Investments | 53.71 | 50.29 | 16.3 | 86.11 | 67.18 | 70.81 |
Other Intangible Assets | 10.22 | 11.12 | 13.44 | 14.07 | 14.03 | 15.96 |
Other Long-Term Assets | 169.74 | 167.97 | 129.28 | 132.85 | 16.17 | 9.54 |
Total Assets | 920.4 | 988.37 | 1,003 | 1,047 | 384.27 | 419.12 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 2.08 | 21.83 | 14.42 | 7.95 | 7.19 | 2.88 |
Accrued Expenses | - | 12.65 | 10.18 | 11.37 | 10.06 | 7.92 |
Short-Term Debt | 29.97 | 67.08 | - | - | - | - |
Current Portion of Long-Term Debt | 26.26 | 16.23 | 12.94 | - | - | - |
Current Portion of Leases | 1.32 | 1.94 | 3.85 | 6.53 | 5.35 | 6.99 |
Current Unearned Revenue | 5.96 | 10.42 | 3.72 | 2.01 | 9.07 | 2.74 |
Other Current Liabilities | 12.76 | 8.27 | 7.39 | 8.85 | 6.64 | 4.31 |
Total Current Liabilities | 78.35 | 138.42 | 52.51 | 36.72 | 38.3 | 24.84 |
Long-Term Debt | 576.35 | 568.63 | 597.46 | 559.4 | - | - |
Long-Term Leases | 2.55 | 1.18 | 2.23 | 5.16 | 4.09 | 7.75 |
Long-Term Deferred Tax Liabilities | - | - | - | - | - | 0.01 |
Other Long-Term Liabilities | 2.86 | 1.71 | 1.88 | 1.57 | 2.13 | 4.3 |
Total Liabilities | 660.11 | 709.94 | 654.08 | 602.85 | 44.52 | 36.9 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 504.65 | 504.65 | 504.65 | 504.65 | 434.65 | 434.65 |
Additional Paid-In Capital | - | - | 105 | 105 | - | - |
Retained Earnings | -239.93 | -219.33 | -251.34 | -172.73 | -100.09 | -57.37 |
Comprehensive Income & Other | -4.43 | -6.89 | -9.25 | 7.18 | 5.19 | 4.95 |
Shareholders' Equity | 260.29 | 278.43 | 349.06 | 444.1 | 339.75 | 382.22 |
Total Liabilities & Equity | 920.4 | 988.37 | 1,003 | 1,047 | 384.27 | 419.12 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 636.45 | 655.05 | 616.49 | 571.1 | 9.43 | 14.74 |
Net Cash (Debt) | -543.86 | -569.6 | -457.84 | -410.32 | 186.16 | 224.35 |
Net Cash Growth | - | - | - | - | -17.02% | -18.67% |
Net Cash Per Share | -10.79 | -11.29 | -9.07 | -9.02 | 4.28 | 5.16 |
Filing Date Shares Outstanding | 50.24 | 50.47 | 50.47 | 50.47 | 43.47 | 43.47 |
Total Common Shares Outstanding | 50.24 | 50.47 | 50.47 | 50.47 | 43.47 | 43.47 |
Working Capital | 71.56 | 80.58 | 197.74 | 217.27 | 220.24 | 261.25 |
Book Value Per Share | 5.18 | 5.52 | 6.92 | 8.80 | 7.82 | 8.79 |
Tangible Book Value | 250.08 | 267.31 | 335.63 | 430.04 | 325.72 | 366.26 |
Tangible Book Value Per Share | 4.98 | 5.30 | 6.65 | 8.52 | 7.49 | 8.43 |
Land | - | 260.61 | 284.6 | 284.6 | - | - |
Buildings | - | 263.57 | 281.35 | 250.31 | 8.67 | - |
Machinery | - | 62.09 | 53.11 | 39.53 | 35.16 | 46.37 |
Construction In Progress | - | 2.1 | 3.17 | 13.11 | - | - |
Leasehold Improvements | - | - | - | - | - | 8.3 |